Table 3.

Summary of network meta-analysis results for tumor response.

Treatment arm	Response a
P value of Overall heterogeneity/inconsistency	0.86
P value of heterogeneity (within designs)	0.86
P value of heterogeneity (between designs)	/
Docetaxel
OR	1.00
P-score (%)	26.5
Anti-PD-1
OR (95% CI)	0.36 (0.25-0.52)
P-score (%)	99.9
Anti-PD-L1
OR (95% CI)	1.02 (0.62-1.66)
P-score (%)	23.5

Abbreviations: PD-1 = programmed death 1; PD-L1 = programmed death ligand 1; OR = odds ratio; CI = confidence interval.

^a The comparison for this endpoint was responders vs. non-responders.